metoprolol has been researched along with Coronary Restenosis in 4 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This research was designed to unveil the impacts of percutaneous coronary intervention via transradial artery access (TRA-PCI) combined with metoprolol on cardiac function and vascular endothelial function in elderly patients with coronary heart disease (CHD)." | 1.91 | Effects of percutaneous coronary intervention via transradial artery access combined with metoprolol on cardiac function and vascular endothelial function in elderly patients with coronary heart disease. ( Cheng, F; Xu, J, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, F | 1 |
| Xu, J | 1 |
| Canbay, A | 1 |
| Ozcan, O | 1 |
| Lau, GT | 1 |
| Ridley, LJ | 1 |
| Bannon, PG | 1 |
| Wong, LA | 1 |
| Trieu, J | 1 |
| Brieger, DB | 1 |
| Lowe, HC | 1 |
| Freedman, BS | 1 |
| Kritharides, L | 1 |
| Franzen, D | 1 |
| Seifert, N | 1 |
| Metha, A | 1 |
| Höpp, HW | 1 |
1 trial available for metoprolol and Coronary Restenosis
| Article | Year |
|---|---|
Metoprolol treatment to prevent restenosis following percutaneous transluminal coronary angioplasty.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Disea | 2002 |
3 other studies available for metoprolol and Coronary Restenosis
| Article | Year |
|---|---|
Effects of percutaneous coronary intervention via transradial artery access combined with metoprolol on cardiac function and vascular endothelial function in elderly patients with coronary heart disease.
Topics: Aged; Coronary Restenosis; Femoral Artery; Humans; Metoprolol; Percutaneous Coronary Intervention; R | 2023 |
In-stent late total occlusion following left main coronary artery stenting.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; A | 2008 |
Lumen loss in the first year in saphenous vein grafts is predominantly a result of negative remodeling of the whole vessel rather than a result of changes in wall thickness.
Topics: Adrenergic beta-Antagonists; Aged; Cohort Studies; Coronary Artery Bypass; Coronary Restenosis; Feas | 2006 |